{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:31:41Z","timestamp":1775665901049,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T00:00:00Z","timestamp":1313539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023817","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T19:45:58Z","timestamp":1313610358000},"page":"e23817","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Regulation of Anthrax Toxin-Specific Antibody Titers by Natural Killer T Cell-Derived IL-4 and IFN\u03b3"],"prefix":"10.1371","volume":"6","author":[{"given":"T. Scott","family":"Devera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay M.","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian A.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy D.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin.","volume":"414","author":"KA Bradley","year":"2001","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin.","volume":"19","author":"RJ Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref3","first-page":"189","article-title":"Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells.","volume":"17","author":"SH Leppla","year":"1984","journal-title":"Adv Cyclic Nucleotide Protein Phosphorylation Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.0707370105","article-title":"Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms.","volume":"105","author":"SL Fink","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1462-5822.2003.00253.x","article-title":"Anthrax toxins and the host: a story of intimacy.","volume":"5","author":"M Mock","year":"2003","journal-title":"Cell Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","article-title":"Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.","volume":"424","author":"A Agrawal","year":"2003","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20041557","article-title":"Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling.","volume":"201","author":"SR Paccani","year":"2005","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.4049\/jimmunol.176.10.6155","article-title":"Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production.","volume":"176","author":"H Fang","year":"2006","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1000588","DOI":"10.1371\/journal.ppat.1000588","article-title":"Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.","volume":"5","author":"SK Joshi","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00015-08","article-title":"Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.","volume":"15","author":"N Abboud","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.","volume":"170","author":"PN Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.","volume":"76","author":"YS Park","year":"2008","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.","volume":"74","author":"KK Peachman","year":"2006","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/IAI.00150-06","article-title":"A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1.","volume":"74","author":"J Rivera","year":"2006","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.","volume":"147","author":"S Welkos","year":"2001","journal-title":"Microbiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.","volume":"190","author":"CP Quinn","year":"2004","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CDLI.12.6.713-721.2005","article-title":"Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.","volume":"12","author":"PR Pittman","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/IAI.00002-10","article-title":"CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.","volume":"78","author":"TS Devera","year":"2010","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.174.9.5681","article-title":"Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.","volume":"174","author":"AA Belperron","year":"2005","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/eji.200738000","article-title":"Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers.","volume":"38","author":"TS Devera","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.4049\/jimmunol.175.5.3309","article-title":"alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.","volume":"175","author":"SY Ko","year":"2005","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1182\/blood-2007-10-117309","article-title":"Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.","volume":"111","author":"GA Lang","year":"2008","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2567.2006.02413.x","article-title":"The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.","volume":"119","author":"GA Lang","year":"2006","journal-title":"Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes.","volume":"23","author":"M Kronenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of Valpha14 NKT cells in innate and acquired immune response.","volume":"21","author":"M Taniguchi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031192","article-title":"Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.","volume":"198","author":"J Schmieg","year":"2003","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.1006662107","article-title":"Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.","volume":"107","author":"X Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1462-5822.2006.00708.x","article-title":"Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.","volume":"8","author":"II Salles","year":"2006","journal-title":"Cell Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/IAI.00749-09","article-title":"The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.","volume":"77","author":"ML Nguyen","year":"2009","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00788-08","article-title":"Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.","volume":"77","author":"ML Nguyen","year":"2009","journal-title":"Infect Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.","volume":"278","author":"T Kawano","year":"1997","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2567.2004.01896.x","article-title":"Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.","volume":"112","author":"GA Lang","year":"2004","journal-title":"Immunology"},{"key":"ref33","first-page":"1610","article-title":"CD1d-dependent B cell help by NKT cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.","volume":"Immun.78","author":"TS Devera","year":"2010","journal-title":"Infect"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice.","volume":"212","author":"RM Martin","year":"1998","journal-title":"J Immunol Methods"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaut.2004.09.008","article-title":"Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.","volume":"23","author":"M Mizuno","year":"2004","journal-title":"J Autoimmun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/intimm\/dxh342","article-title":"Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo.","volume":"17","author":"S Oki","year":"2005","journal-title":"Int Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae.","volume":"87","author":"ED Williamson","year":"1999","journal-title":"J Appl Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.","volume":"72","author":"N Mohamed","year":"2004","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","article-title":"The IL-4 receptor: signaling mechanisms and biologic functions.","volume":"17","author":"K Nelms","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses.","volume":"21","author":"SJ Szabo","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1084\/jem.20100995","article-title":"A requirement for FcgammaR in antibody-mediated bacterial toxin neutralization.","volume":"207","author":"N Abboud","year":"2010","journal-title":"J Exp Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:15:24Z","timestamp":1592824524000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023817"}},"subtitle":[],"editor":[{"given":"Dennis W.","family":"Metzger","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023817","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}